Corbion Appoints Sven Thormählen as Chief Technology Officer (CTO)

09 Dec 2013 --- Corbion has announced that Sven Thormählen will join as Chief Technology Officer, effective 1 April 2014. As Chief Technology Officer, Sven Thormählen assumes responsibility for the global R&D organization.

He will be responsible for driving Corbion’s innovation and technology agenda to enable the business development opportunities to continue the company's growth journey. Sven will be nominated for appointment as a member of the Board of Management at the Corbion annual shareholders meeting scheduled for 12 May 2014.

Sven Thormählen holds a Ph.D. in Synthetic Organic Chemistry from the University of Hamburg. Previously, he was Executive Vice President R&D and executive board member of the Danone Group based in France, Senior Vice President Research and Development at L'Oréal based in the United States and he held several R&D leadership positions at Beiersdorf in Germany and the United States.

Currently, Sven is Chief Executive Officer, at MucoVax GmbH , a privately owned specialty medical products company in Hamburg, Germany. In addition, he serves on the Board of Accera Inc. and on various research committees. Sven Thormählen is of German nationality.

Gerard Hoetmer, CEO Corbion: "Corbion is transforming into a leading biobased products company, growing from our core technol ogies and expanding in adjacent technology and product platforms. Innovation in terms of new formulations and strategic technology development is key to our growth strategy. To further enforce the strategic importance of science in our company we incorpora te a dedicated CTO position in our Board of Management. Corbion has an excellent innovation track record and I believe Sven's experience in global R&D activities, integrating international research and development teams and his significant international an d broad industry experience make him well positioned to lead Corbion's R&D organization and drive Corbion’s innovation agenda further."